SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

USELESS

USELESS CRYPTO is trending amidst reports of significant accumulation by major crypto whales and its growing presence on top exchanges, including integration with Chainlink CCIP. The community is highly engaged, embracing the token's ironic 'useless' name as a unique and relatable narrative that fuels speculative predictions for a multi-billion market capitalization. Enthusiasts are actively buying dips, anticipating a massive parabolic run and positioning it as a potential leader in the meme coin sector.

SuperRare

SuperRare ($RARE) is generating significant discussion and high trading volume, with many community members identifying bullish technical patterns and potential for a breakout. While some view its NFT platform fundamentals and tokenomics favorably, others express caution given past volatility and recent token transfers to exchanges. The token's near-complete vesting schedule is also a central talking point, influencing varied market outlooks.

Wishing Well

WISH CRYPTO is trending with its community actively engaged in a weekend event, following recent listings on platforms like CoinGecko and anticipation for its full chart integration on StockTwits. The project is garnering attention for its unique deflationary tokenomics, which includes monthly burns tied to US inflation, and its long-term vision as a "digital wishing well" backed by a mature stock community focused on HODLers.

Atlas Critical Minerals Corp. is a mineral exploration company, which focuses on minerals projects and properties in Brazil. The firm also operates an iron ore mine Its portfolio includes mineral properties for rare earths, graphite, uranium, titanium, copper, nickel, iron ore, gold, and quartzite. The company was founded by Marc Fogassa on July 27, 2016 and is headquartered in Belo Horizonte, Brazil.

Atlas Critical Minerals Corp.

Atlas Critical Minerals Corp. is trending following its recent Nasdaq uplisting, fueled by confirmed nuclear grade graphite and initial revenue from iron ore operations in Brazil. The community is actively discussing the company's diversified critical minerals portfolio and strategic Brazilian landholdings, especially in light of a new EU trade deal with the Mercosur bloc and perceived undervaluation compared to sector peers. These developments, coupled with a low share float, are generating significant investor interest.

Martin Marietta Materials, Inc. is a natural resource-based building materials company, which engages in the provision of aggregates including crushed stone, sand, and gravel through its network of quarries and distribution yards. It operates through the East Group and West Group segments. The East Group segment offers aggregates and asphalt products. The West Group segment focuses on aggregates, cement, downstream products, and paving services. The company was founded on November 12, 1993 and is headquartered in Raleigh, NC.

Martin Marietta Materials, Inc.

Martin Marietta Materials is trending higher amid strong analyst sentiment highlighting its robust pricing power and increased shipments in the construction materials sector. Community discussion centers on the company's strategic portfolio optimization, including recent acquisitions and divestitures, positioning it as a key beneficiary of sustained government infrastructure spending. This focus on high-margin aggregates is resonating with investors, who see continued strength in its core business.

LendingClub Corp. engages in the operations of digital marketplace bank. It operates through the LendingClub Bank and LendingClub Corporation (Parent Only) segments. The LendingClub Bank segment involves the provision of full complement of financial products and solutions, loans, leases, and deposits. The LendingClub Corporation (Parent Only) segment includes the holding company legal entity. The company was founded by Renaud Laplanche and Soulaiman Htite in 2006 and is headquartered in San Francisco, CA.

LendingClub Corp

LendingClub is experiencing heightened interest following a significant upgrade from J.P. Morgan and the announcement of a substantial stock repurchase program. The community is actively discussing these catalysts, alongside the company's strategic expansion into home improvement lending and upcoming rebranding efforts. Many view LC as a robust, undervalued fintech poised to benefit from a more favorable interest rate environment.

Enbridge, Inc. engages in the provision of gas and oil. It operates through the following segments: Liquid Pipelines, Gas Distribution and Storage, Gas Transmission and Midstream, Renewable Power Generation, and Energy Services. The Liquids Pipelines segment consists of common carrier and contract crude oil, natural gas liquids and refined products pipelines and terminals in Canada and the U.S., including Canadian Mainline, Regional Oil Sands System, Southern Lights Pipeline, Spearhead Pipeline, Seaway Crude Pipeline interest, and other feeder pipelines. The Gas Distribution & Storage segment consists of natural gas utility operations, the core of which is Enbridge gas, which serves residential, commercial and industrial customers. It also includes natural gas distribution activities in Quebec and an investment in Noverco, which holds a majority interest in a subsidiary entity engaged in distribution and energy transportation primarily in Quebec. The Gas Transmission & Midstream segment consists of investments in natural gas pipelines, processing and green energy projects, the company's commodity marketing businesses, and international activities. The Renewable Power Generation segment consists primarily of investments in wind and solar power generating assets, as well as geothermal, waste heat recovery, and transmission assets. The Energy Services segment consists of businesses in Canada and the United States including logistical services, refinery supply services and the firm's volume commitments on various pipeline systems. The company was founded on April 30, 1949 and is headquartered in Calgary, Canada.

Enbridge Inc

Enbridge is trending as analysts highlight a brightening outlook for midstream energy, driven by robust natural gas demand from data centers and LNG exports, alongside strategic pipeline expansions. The investment community is focused on its consistent dividend growth and stable, fee-based cash flows, largely secured by long-term contracts. Recent positive legal and project developments further bolster confidence in its predictable income profile within the evolving energy sector.

SSgA Active Trust - State Street Consumer Staples Select Sector SPDR ETF

Consumer Staples Select Sector SPDR Fund

Consumer Staples Select Sector SPDR Fund (XLP) is trending as investors actively rotate into defensive assets, driven by strong technical signals and a perception of being undervalued after a period of underperformance. The community is buzzing about XLP's renewed bullish momentum, viewing it as a critical safe haven amidst broader market uncertainties and concerns about valuations in other sectors.

CD Projekt SA is a holding company, which engages in the development of video games. It operates through the CD PROJEKT RED and GOG.com segments. The CD PROJEKT RED segment focuses on videogame development. The GOG.com segment distributes global digital videogame. Its other activities include motion picture distribution and investment services. The company was founded by Marcin Piotr Iwinski in 1994 and is headquartered in Warsaw, Poland.

CD Projekt S.A. - ADR

CD Projekt 4 ADR Representing Ord Shs

OTGLY is experiencing significant buzz amid widespread anticipation for new Witcher 3 content and robust, ongoing sales of Cyberpunk 2077 and its Phantom Liberty expansion. The community is actively discussing the confirmed full-scale production of The Witcher 4 and progress on Cyberpunk 2, fueling optimism about the developer's strong pipeline and financial performance despite debates over future game themes and release timelines.

Dutch Bros, Inc. engages in operating and franchising drive-thru shops that focus on handcrafted beverages. It operates through the Company-Operated Shops, and Franchising and Other segments. The Company-Operated Shops segment consists of coffee shop sales to customers. The Franchising and Other segment is involved in bean and product sales to franchisees and includes the initial franchise fees, royalties, and marketing fees. The company was founded by Travis Boersma and Dane Boersma in 1992 and is headquartered in Tempe, AZ.

Dutch Bros Inc - Ordinary Shares - Class A

Dutch Bros Inc

Dutch Bros is currently trending due to its strong Q3 earnings beat and raised guidance, which has spurred multiple analyst upgrades and price target increases. The company's aggressive expansion strategy, including new store openings and a push into grocery retail and hot food, is resonating with a loyal customer base, despite ongoing community debate about its premium valuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Corvus Pharmaceuticals (NASDAQ:CRVS) Shares Up 7.1% - Still a Buy?

Corvus Pharmaceuticals (NASDAQ:CRVS) Shares Up 7.1% - Should You Buy...

Corvus Pharmaceuticals (NASDAQ:CRVS) Stock Price Down 6.5% - Should You Sell?

Corvus Pharmaceuticals (NASDAQ:CRVS) Trading Down 6.5% - Time to Sell...

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Given Average Rating of "Moderate Buy" by Brokerages

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS - Get Free Report) has earned a consensus rating of "Moderate Buy" from the six research firms that are currently covering the firm, MarketBeat reports. One...

Corvus Pharmaceuticals (NASDAQ:CRVS) Shares Up 3.5% - Here's Why

Corvus Pharmaceuticals (NASDAQ:CRVS) Stock Price Up 3.5% - Still a Buy...

Corvus Pharmaceuticals (NASDAQ:CRVS) Trading 7.1% Higher - What's Next?

Corvus Pharmaceuticals (NASDAQ:CRVS) Shares Up 7.1% - Here's Why...

Corvus Pharmaceuticals (NASDAQ:CRVS) Sets New 12-Month High - Here's What Happened

Corvus Pharmaceuticals (NASDAQ:CRVS) Sets New 12-Month High - Should You Buy...

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Receives Average Rating of "Moderate Buy" from Analysts

Shares of Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS - Get Free Report) have earned a consensus rating of "Moderate Buy" from the five brokerages that are currently covering the firm, MarketBeat...

Foresite Capital Management VI LLC Boosts Position in Corvus Pharmaceuticals, Inc. $CRVS

Foresite Capital Management VI LLC lifted its position in shares of Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS - Free Report) by 9.5% in the 2nd quarter, according to its most recent disclosure with...

BML Capital Management LLC Buys New Stake in Corvus Pharmaceuticals, Inc. $CRVS

BML Capital Management LLC bought a new stake in Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with...

Corvus Pharmaceuticals (NASDAQ:CRVS) Trading Up 7.4% - Still a Buy?

Corvus Pharmaceuticals (NASDAQ:CRVS) Trading 7.4% Higher - What's Next...

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.13	--	--	N/A
Q3 '25	-$0.13	-$0.12	5.47%	BEAT
Q2 '25	-$0.13	-$0.10	25.00%	BEAT
Q1 '25	-$0.12	-$0.13	-8.33%	MISSED
Q4 '24	-$0.12	-$0.18	-54.29%	MISSED

CRVS
Corvus Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest CRVS News

CRVSCorvus Pharmaceuticals Inc